News and Events
Galt Pharmaceuticals Answers the Call for Better Practices in Pain Management with a Non-opioid Therapeutic Alternative
May 29, 2019
Officials with the FDA have given Priority Review designation to an opioid-free pain management treatment from Galt Pharmaceuticals.
According to the company, its Supplemental Abbreviated New Drug Application for the orphenadrine citrate, aspirin and caffeine combination (Orphengesic Forte), a muscle relaxant pain reliever, was given ...
Innovative Pharma Company Galt Signs 50th Franchise
February 14, 2019
ATLANTA--(BUSINESS WIRE)--The first and only pharmaceutical company to create a unique franchise pharma concept referred to as “phranchising,” Galt Pharmaceuticals recently signed its 50th territory.
“Our unique model offers the right entrepreneur the opportunity to run their own pharmaceutical company in their local market using a very patient-centric approach to educating healthcare providers,” said Galt CEO and co-founder Barry Patel, Pharm.D.
Validating this transformative model, Atlanta-based Galt brought on ...
Pharmaceutical Franchising Introduced by Galt Phranchise Systems and Holds First Training Class
April 4, 2018
ATLANTA, GA Galt Phranchise Systems, LLC (GPS) announces the launch of the pharmaceutical industry’s first franchising model. GPS is the first and only pharmaceutical company which operates a sales platform based upon the spirit of entrepreneurialism through Phranchising (Pharmaceutical Franchising). Over 500 sales territories ...
Galt Pharmaceuticals Announces Acquisition of Cutis Health
January 22, 2017
Atlanta, GA: Galt Pharmaceuticals, LLC announces the acquisition of Cutis Health, LLC. The transaction includes Cutis Health's prescription and non-prescription products as well as its intellectual property and registered marks. Dr. Barry Patel, President & CEO of Galt, stated, “Integrating the Cutis Health brand ...
Mercer College of Pharmacy and Galt Pharmaceuticals Partners on Industry Fellowship
January 12, 2017
ATLANTA - The College of Pharmacy has established a pharmaceutical industry fellowship with Atlanta-based Galt Pharmaceuticals. The one-year fellowship is for a pharmacy graduate interested in a career in the pharmaceutical industry.
Cutis Health Announces Acquisition of Doral
April 6, 2016
Atlanta GA: Cutis Health, LLC, a specialty pharmaceutical company based in Atlanta acquires Doral (Quazepam) from Sciecure Pharma, Inc. In addition to the product New Drug Application (NDA), the acquisition includes significant inventory with extended dating. “We are pleased to re-introduce Doral to the ...